Dr. Ted Fjällman Fjallman is the CEO of Prokarium, a London-based biotech developing microbial immunotherapy and vaccines.
— Sachs Associates (@SachsAssociates) September 8, 2020
e-Meet Ted at #Sachs_BEF
More info @ https://t.co/XI3zEYGyl2 pic.twitter.com/8Leoa6OEFR
